Literature DB >> 28115389

Hypo-methylation mediates chromosomal instability in pancreatic NET.

I Marinoni1, A Wiederkeher2, T Wiedmer2,3, S Pantasis2, A Di Domenico2,3, R Frank2, E Vassella2, A Schmitt2, A Perren2.   

Abstract

DAXX and or ATRX loss occur in 40% of pancreatic neuroendocrine tumors (PanNETs). PanNETs negative for DAXX or ATRX show an increased risk of relapse. The tumor-associated pathways activated upon DAXX or ATRX loss and how this event may induce chromosomal instability (CIN) and alternative lengthening telomeres (ALT) are still unknown. Both DAXX and ATRX are involved in DNA methylation regulation. DNA methylation of heterochromatin and of non-coding sequences is extremely important for the maintenance of genomic stability. We analyzed the association of DAXX and/or ATRX loss and CIN with global DNA methylation in human PanNET samples and the effect of DAXX knock-down on methylation and cell proliferation. We assessed LINE1 as well as global DNA methylation in 167 PanNETs, and we found that DAXX and or ATRX-negative tumors and tumors with CIN were hypomethylated. DAXX knock-down in PanNET cell lines blocked cells in G1/G0 phase and seemed to increase CIN in QGP-1 cells. However, no direct changes in DNA methylation were observed after DAXX knock-down in vitro In conclusion, our data indicate that epigenetic changes are crucial steps in the progression of PanNETs loss and suggest that DNA methylation is the mechanism via which CIN is induced, allowing clonal expansion and selection.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  DAXX and ATRX; DNA methylation; chromosomal instability; pancreatic neuroendocrine tumors

Mesh:

Substances:

Year:  2017        PMID: 28115389     DOI: 10.1530/ERC-16-0554

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  9 in total

1.  Retrotransposons and genetic instability in hepatocellular carcinoma.

Authors:  Ruchi Shukla
Journal:  Hepat Oncol       Date:  2017-07-18

Review 2.  Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.

Authors:  Sucharitha Iyer; Sunita K Agarwal
Journal:  J Mol Endocrinol       Date:  2018-04-03       Impact factor: 5.098

Review 3.  Neuroendocrine Neoplasms of the Small Bowel and Pancreas.

Authors:  Ashley Kieran Clift; Mark Kidd; Lisa Bodei; Christos Toumpanakis; Richard P Baum; Kjell Oberg; Irvin M Modlin; Andrea Frilling
Journal:  Neuroendocrinology       Date:  2019-09-27       Impact factor: 5.135

Review 4.  Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium.

Authors:  Andrea Mafficini; Aldo Scarpa
Journal:  J Endocrinol       Date:  2018-01-10       Impact factor: 4.286

Review 5.  Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.

Authors:  Martine Bocchini; Fabio Nicolini; Stefano Severi; Alberto Bongiovanni; Toni Ibrahim; Giorgia Simonetti; Ilaria Grassi; Massimiliano Mazza
Journal:  Front Oncol       Date:  2020-05-27       Impact factor: 6.244

6.  Reduced DAXX Expression Is Associated with Reduced CD24 Expression in Colorectal Cancer.

Authors:  Ya-Chun Chen; Tsung-Hsien Lee; Shu-Ling Tzeng
Journal:  Cells       Date:  2019-10-12       Impact factor: 6.600

7.  DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association.

Authors:  Vanessa Lakis; Rita T Lawlor; Felicity Newell; Ann-Marie Patch; Andrea Mafficini; Anguraj Sadanandam; Lambros T Koufariotis; Rebecca L Johnston; Conrad Leonard; Scott Wood; Borislav Rusev; Vincenzo Corbo; Claudio Luchini; Sara Cingarlini; Luca Landoni; Roberto Salvia; Michele Milella; David Chang; Peter Bailey; Nigel B Jamieson; Fraser Duthie; Marie-Claude Gingras; Donna M Muzny; David A Wheeler; Richard A Gibbs; Massimo Milione; Paolo Pederzoli; Jaswinder S Samra; Anthony J Gill; Amber L Johns; John V Pearson; Andrew V Biankin; Sean M Grimmond; Nicola Waddell; Katia Nones; Aldo Scarpa
Journal:  Commun Biol       Date:  2021-02-03

8.  Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour.

Authors:  Tiago Bordeira Gaspar; Sofia Macedo; Ana Sá; Mariana Alves Soares; Daniela Ferreira Rodrigues; Mafalda Sousa; Nuno Mendes; Rui Sousa Martins; Luís Cardoso; Inês Borges; Sule Canberk; Fátima Gärtner; Leandro Miranda-Alves; Manuel Sobrinho-Simões; José Manuel Lopes; Paula Soares; João Vinagre
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

9.  Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors.

Authors:  Seyoun Byun; Kajsa E Affolter; Angela K Snow; Karen Curtin; Austin R Cannon; Lisa A Cannon-Albright; Ramya Thota; Deborah W Neklason
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.